- Home
- SOPH vs SPXX Comparison
SOPH vs SPXX Comparison
Compare SOPH & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOPH | SPXX |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 323.0M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SOPH | SPXX |
|---|---|---|
| Price | $4.66 | $17.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 102.9K | ★ 230.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $15.78 |
| 52 Week High | $5.70 | $18.35 |
Technical Indicators
Market Signals| Indicator | SOPH | SPXX |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 61.58 |
| Support Level | $4.56 | $17.66 |
| Resistance Level | $4.86 | $17.86 |
| Average True Range (ATR) | 0.36 | 0.15 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 17.01 | 66.89 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35% to 75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.